Back to search

Article

Helospectin from Heloderma Venom: A VIP‐Like Vasodilatory Peptide for Erectile Dysfunction and Clitoral Engorgement—A Theoretical Preclinical Proposal

2025-12-08

Abstract excerpt

<h4>Background: </h4> Erectile dysfunction (ED) affects approximately 52% of men aged 40–70 years in population-based cohorts and is strongly associated with vascular and metabolic disease, particularly diabetes mellitus.[1] In Saudi Arabia, diabetes prevalence in adults is estimated at over 20%, magnifying the burden of vasculogenic ED.[2] Phosphodiesterase-5 inhibitors (PDE5i) improve erectile function but have...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
03fe13cf-0321-52b5-9f47-a547b5a4f406
DOI
10.20944/preprints202512.0658.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Helospectin from Heloderma Venom: A VIP‐Like Vasodilatory Peptide for Erectile Dysfunction and Clitoral Engorgement—A Theoretical Preclinical ProposalDOI 10.20944/preprints202512.0658.v1
Select a neighboring publication to make it the new centre.